HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shoji Sanada Selected Research

Fibrosis (Cirrhosis)

1/2016Targeted Therapy for Acute Autoimmune Myocarditis with Nano-Sized Liposomal FK506 in Rats.
5/2013Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice.
11/2009Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling.
6/2007IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
4/2006The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shoji Sanada Research Topics

Disease

20Heart Failure
01/2021 - 05/2003
14Ischemia
12/2017 - 01/2002
14Infarction (Infarctions)
12/2017 - 01/2002
12Reperfusion Injury
12/2017 - 01/2002
9Cardiomegaly (Heart Hypertrophy)
01/2016 - 01/2002
9Myocardial Ischemia (Ischemic Heart Diseases)
05/2007 - 07/2002
7Myocardial Infarction
12/2017 - 01/2002
7Hypertrophy
01/2012 - 09/2002
6Coronary Occlusion
12/2004 - 01/2002
5Fibrosis (Cirrhosis)
01/2016 - 04/2006
3Neoplasms (Cancer)
03/2016 - 03/2002
3Ventricular Fibrillation
01/2005 - 01/2002
3Body Weight (Weight, Body)
08/2004 - 09/2002
2Inflammation (Inflammations)
01/2016 - 04/2006
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Infections
10/2020
1COVID-19
10/2020
1Atherosclerotic Plaque (Atheroma)
11/2018
1Bradycardia
12/2017
1Hypotension (Low Blood Pressure)
12/2017
1Cardiotoxicity
03/2016
1Myocarditis (Carditis)
01/2016
1Glucose Intolerance
05/2013
1Diabetes Mellitus
05/2013
1Cardiac Arrhythmias (Arrythmia)
04/2013

Drug/Important Bio-Agent (IBA)

9Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2017 - 01/2002
9Proteins (Proteins, Gene)FDA Link
03/2016 - 09/2002
6Adenosine (Adenocard)FDA LinkGeneric
06/2008 - 01/2002
6NG-Nitroarginine Methyl Ester (L-NAME)IBA
04/2006 - 01/2002
55'-Nucleotidase (5' Nucleotidase)IBA
06/2008 - 09/2003
4Nitric Oxide Synthase (NO Synthase)IBA
04/2006 - 01/2002
4Phosphotransferases (Kinase)IBA
01/2005 - 09/2002
4Raloxifene Hydrochloride (Evista)FDA Link
06/2004 - 01/2002
4Selective Estrogen Receptor Modulators (SERM)IBA
06/2004 - 01/2002
3Interleukin-33IBA
01/2017 - 06/2007
3Pharmaceutical PreparationsIBA
01/2016 - 04/2005
3Adenosine Triphosphate (ATP)IBA
06/2012 - 09/2002
3Angiotensin IIIBA
01/2012 - 10/2003
3Charybdotoxin (ChTX)IBA
12/2004 - 09/2002
38-(4-sulfophenyl)theophyllineIBA
10/2004 - 01/2002
370-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
04/2003 - 09/2002
2Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
11/2018 - 01/2002
2Glucose (Dextrose)FDA LinkGeneric
03/2016 - 06/2010
2Messenger RNA (mRNA)IBA
01/2016 - 07/2010
2Anti-Arrhythmia AgentsIBA
04/2013 - 01/2005
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2012 - 10/2004
2Angiotensin Receptor AntagonistsIBA
01/2012 - 05/2003
2Ion Channels (Ion Channel)IBA
11/2011 - 02/2010
2Histamine (Histamine Dihydrochloride)FDA Link
11/2010 - 05/2006
2Adrenergic Receptors (Adrenergic Receptor)IBA
11/2010 - 06/2004
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2010 - 01/2002
2Mineralocorticoid Receptor AntagonistsIBA
04/2006 - 05/2003
2AldosteroneIBA
04/2006 - 07/2005
2Protein Kinase CIBA
07/2005 - 07/2004
2WortmanninIBA
01/2005 - 10/2004
2Celiprolol (ST1396)IBA
08/2004 - 04/2003
2Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2003 - 01/2002
2Endothelin-1 (Endothelin 1)IBA
10/2003 - 09/2003
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2003 - 07/2002
2PotassiumIBA
01/2003 - 09/2002
2Hydralazine (Apresoline)FDA LinkGeneric
01/2003 - 09/2002
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2003 - 09/2002
1empagliflozinIBA
01/2021
1Small Interfering RNA (siRNA)IBA
11/2018
1neutravidinIBA
11/2018
1Apolipoproteins E (ApoE)IBA
11/2018
1Biotin (Vitamin H)FDA Link
11/2018
1ApolipoproteinsIBA
11/2018
1nitroxylIBA
12/2017
1tempolIBA
12/2017
1Free RadicalsIBA
12/2017
1TEMPOIBA
12/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2016
1Liposomes (Liposome)IBA
01/2016
1CytokinesIBA
01/2016
1InterferonsIBA
01/2016
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2016
1Recombinant DNA (Recombinant DNA Research)IBA
01/2016
1Tacrolimus (Prograf)FDA LinkGeneric
01/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016
1human NPPA protein (carperitide)IBA
08/2014
1DiureticsIBA
08/2014
1Guanosine Monophosphate (5' Guanylic Acid)IBA
08/2014
1Peptides (Polypeptides)IBA
08/2014
1VildagliptinIBA
05/2013
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
05/2013
1Hormones (Hormone)IBA
05/2013
1Glucagon-Like Peptide 1 (GLP 1)IBA
05/2013
1Dipeptidyl-Peptidase IV InhibitorsIBA
05/2013
1IncretinsIBA
05/2013
1Amiodarone (Amiodarona)FDA LinkGeneric
04/2013
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
06/2012
1HydrogenIBA
06/2012

Therapy/Procedure

7Therapeutics
01/2021 - 01/2002
2Intravenous Administration
04/2013 - 01/2005
2Ligation
01/2012 - 04/2005
1Ambulatory Care (Outpatient Care)
10/2020
1Intravenous Injections
11/2018
1Lasers (Laser)
11/2018